Antibiotic resistance among gram-negative bacilli in US intensive care units: implications for fluoroquinolone use.
暂无分享,去创建一个
J. Quinn | R. Weinstein | R. Rydman | L. Danziger | Robert A Weinstein | M. Neuhauser | Melinda M Neuhauser | Robert Rydman | Larry H Danziger | George Karam | John P Quinn | G. Karam
[1] T. Köhler,et al. Characterization of MexT, the Regulator of the MexE-MexF-OprN Multidrug Efflux System of Pseudomonas aeruginosa , 1999, Journal of bacteriology.
[2] C. Soussy,et al. In-vitro activity of moxifloxacin against fluoroquinolone-resistant strains of aerobic gram-negative bacilli and Enterococcus faecalis. , 1999, The Journal of antimicrobial chemotherapy.
[3] R. Gaynes,et al. Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: project ICARE phase 2. Project Intensive Care Antimicrobial Resistance Epidemiology (ICARE) hospitals. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[4] R. Gaynes,et al. Antimicrobial resistance in isolates from inpatients and outpatients in the United States: increasing importance of the intensive care unit. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[5] L E Nilsson,et al. Antibiotic susceptibility among aerobic gram-negative bacilli in intensive care units in 5 European countries. French and Portuguese ICU Study Groups. , 1999, JAMA.
[6] Nnis System. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2003, issued August 2003. , 2003, American journal of infection control.
[7] G. Jacoby,et al. Quinolone resistance from a transferable plasmid , 1998, The Lancet.
[8] National Nosocomial Infections Surveillance (NNIS) system report, data summary from January 1992-April 2000, issued June 2000. , 2000, American journal of infection control.
[9] Ronald N. Jones,et al. Characterization of Pseudomonas aeruginosa isolates: occurrence rates, antimicrobial susceptibility patterns, and molecular typing in the global SENTRY Antimicrobial Surveillance Program, 1997-1999. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[10] W. Bilker,et al. Epidemiological investigation of fluoroquinolone resistance in infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[11] D. McClish,et al. Nosocomial bloodstream infections in United States hospitals: a three-year analysis. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[12] R A Weinstein,et al. Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes. , 1999, JAMA.
[13] J. Bartlett,et al. Principles of Appropriate Antibiotic Use for Treatment of Acute Respiratory Tract Infections in Adults: Background, Specific Aims, and Methods , 2001, Annals of Internal Medicine.
[14] H. Goossens,et al. Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum beta-lactamase production in Klebsiella pneumoniae isolates causing bacteremia. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[15] S. Levy,et al. Carriage of antibiotic-resistant fecal bacteria in Nepal reflects proximity to Kathmandu. , 2001, The Journal of infectious diseases.
[16] J. Quinn,et al. Antimicrobial resistance rates among aerobic gram-negative bacilli recovered from patients in intensive care units: evaluation of a national postmarketing surveillance program. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[17] D. Hooper,et al. Mechanisms of action and resistance of older and newer fluoroquinolones. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.